IRIS Accounts Production v23.3.0.418 06715707 director 1.11.21 31.10.22 31.10.22 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067157072021-10-31067157072022-10-31067157072021-11-012022-10-31067157072020-10-31067157072020-11-012021-10-31067157072021-10-3106715707ns10:Originalns15:EnglandWales2021-11-012022-10-3106715707ns14:PoundSterlingns10:Original2021-11-012022-10-3106715707ns10:Originalns10:Director12021-11-012022-10-3106715707ns10:Original2021-11-012022-10-3106715707ns10:Original2022-10-3106715707ns10:Originalns10:PrivateLimitedCompanyLtd2021-11-012022-10-3106715707ns10:Originalns10:SmallEntities2021-11-012022-10-3106715707ns10:Originalns10:AuditExempt-NoAccountantsReport2021-11-012022-10-3106715707ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2021-11-012022-10-3106715707ns10:SmallCompaniesRegimeForAccountsns10:Original2021-11-012022-10-3106715707ns10:Originalns10:FullAccounts2021-11-012022-10-3106715707ns10:Original2020-11-012021-10-3106715707ns10:Originalns10:OrdinaryShareClass12021-11-012022-10-3106715707ns10:CompanySecretary1ns10:Original2021-11-012022-10-3106715707ns10:Originalns10:RegisteredOffice2021-11-012022-10-3106715707ns10:Original2021-10-3106715707ns10:Originalns5:CurrentFinancialInstruments2022-10-3106715707ns10:Originalns5:CurrentFinancialInstruments2021-10-3106715707ns10:Originalns5:Non-currentFinancialInstruments2022-10-3106715707ns10:Originalns5:Non-currentFinancialInstruments2021-10-3106715707ns5:ShareCapitalns10:Original2022-10-3106715707ns5:ShareCapitalns10:Original2021-10-3106715707ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3106715707ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-10-3106715707ns10:Originalns5:PlantMachinery2021-11-012022-10-3106715707ns10:Originalns5:PlantMachinery2021-10-3106715707ns10:Originalns5:PlantMachinery2022-10-3106715707ns10:Originalns5:PlantMachinery2021-10-3106715707ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3106715707ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-10-3106715707ns10:Originalns10:OrdinaryShareClass12022-10-31
REGISTERED NUMBER: 06715707 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31 October 2022

for

Nemesis Medical Limited

Nemesis Medical Limited (Registered number: 06715707)






Contents of the Financial Statements
for the Year Ended 31 October 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Nemesis Medical Limited

Company Information
for the Year Ended 31 October 2022







DIRECTOR: D Cook





SECRETARY: Mrs N Cook





REGISTERED OFFICE: Wyvols Court
Basingstoke Road
Swallowfield
Reading
Berkshire
RG7 1WY





REGISTERED NUMBER: 06715707 (England and Wales)





ACCOUNTANTS: J & C Accountants Ltd
Wyvols Court
Basingstoke Road
Swallowfield
Reading
Berkshire
RG7 1WY

Nemesis Medical Limited (Registered number: 06715707)

Balance Sheet
31 October 2022

31.10.22 31.10.21
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,733 1,417

CURRENT ASSETS
Stocks 101,900 134,400
Debtors 5 7,140 38,800
Cash at bank - 21,388
109,040 194,588
CREDITORS
Amounts falling due within one year 6 98,414 141,946
NET CURRENT ASSETS 10,626 52,642
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,359

54,059

CREDITORS
Amounts falling due after more than
one year

7

100,806

117,909
NET LIABILITIES (88,447 ) (63,850 )

CAPITAL AND RESERVES
Called up share capital 8 5 5
Retained earnings (88,452 ) (63,855 )
SHAREHOLDERS' FUNDS (88,447 ) (63,850 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2022 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Nemesis Medical Limited (Registered number: 06715707)

Balance Sheet - continued
31 October 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 October 2023 and were signed by:





D Cook - Director


Nemesis Medical Limited (Registered number: 06715707)

Notes to the Financial Statements
for the Year Ended 31 October 2022

1. STATUTORY INFORMATION

Nemesis Medical Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 06715707. The registered office is Wyvols Court, Basingstoke Road, Swallowfield, Reading, Berkshire, RG7 1WY. The business address is S10 3rd Floor Broadway House, 4-8 The Broadway, Newbury, Berkshire, RG14 1BA.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Nemesis Medical Limited (Registered number: 06715707)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2021 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 November 2021 5,436
Additions 1,243
At 31 October 2022 6,679
DEPRECIATION
At 1 November 2021 4,000
Charge for year 946
At 31 October 2022 4,946
NET BOOK VALUE
At 31 October 2022 1,733
At 31 October 2021 1,436

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Trade debtors - 23,400
Other debtors 7,140 15,400
7,140 38,800

Nemesis Medical Limited (Registered number: 06715707)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.22 31.10.21
£    £   
Bank loans and overdrafts 31,566 36,538
Trade creditors - 80,047
Taxation and social security 3,279 3,225
Other creditors 63,569 22,136
98,414 141,946

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.10.22 31.10.21
£    £   
Bank loans 100,806 117,909

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 41,537 54,370

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.22 31.10.21
value: £    £   
5 Ordinary £1.00 5 5

9. FUNDAMENTAL UNCERTAINTIES AFFECTING THE ACCOUNTS

The director draws attention to the deficiency of assets shown in the accounts. The company continued to trade through the support of its creditors, and the financial statements have been drawn up on a going concern basis which assumes the support will continue.

Should the company be unable to continue trading, adjustments would have to be made to reduce the value of the assets to their recoverable amount, to provide for any further liabilities which might arise and to reclassify fixed assets and long term liabilities as current assets and current liabilities. The director has been unable to quantify the potential adjustment to the asset values which would be necessary in this situation, nor the further liabilities which would arise.